Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states.

BMC Cancer
Aaron L SarverClifford J Steer

Abstract

Colon cancer arises from the accumulation of multiple genetic and epigenetic alterations to normal colonic tissue. microRNAs (miRNAs) are small, non-coding regulatory RNAs that post-transcriptionally regulate gene expression. Differential miRNA expression in cancer versus normal tissue is a common event and may be pivotal for tumor onset and progression. To identify miRNAs that are differentially expressed in tumors and tumor subtypes, we carried out highly sensitive expression profiling of 735 miRNAs on samples obtained from a statistically powerful set of tumors (n = 80) and normal colon tissue (n = 28) and validated a subset of this data by qRT-PCR. Tumor specimens showed highly significant and large fold change differential expression of the levels of 39 miRNAs including miR-135b, miR-96, miR-182, miR-183, miR-1, and miR-133a, relative to normal colon tissue. Significant differences were also seen in 6 miRNAs including miR-31 and miR-592, in the direct comparison of tumors that were deficient or proficient for mismatch repair. Examination of the genomic regions containing differentially expressed miRNAs revealed that they were also differentially methylated in colon cancer at a far greater rate than would be expected by cha...Continue Reading

References

Jun 22, 2002·Gut·R SalovaaraL A Aaltonen
Feb 19, 2003·Nature Genetics·Michael NicolasFreddy Radtke
Feb 13, 2004·Bioinformatics·Laurent GautierRafael A Irizarry
Mar 26, 2005·Science·Freddy Radtke, Hans Clevers
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jan 4, 2006·Surgical Oncology Clinics of North America·Josh Kehoe, Vijay P Khatri
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Mar 1, 2006·Current Opinion in Genetics & Development·Richard W Carthew
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Oct 13, 2006·The Oncologist·Al B Benson
Feb 9, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J FerlayP Boyle
Jul 20, 2007·Molecular and Cellular Biology·Zhijun DuanMarshall S Horwitz
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yoshiyuki WatanabeTakashi Tokino
Oct 20, 2007·The Journal of Pathology·U LehmannH Kreipe
Jan 31, 2008·JAMA : the Journal of the American Medical Association·Aaron J SchetterCurtis C Harris
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 20, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Simon K ChanSteven J M Jones
Mar 26, 2008·Nature Biotechnology·Nitzan RosenfeldIris Barshack
May 13, 2008·Gastroenterology·Brian M Wolpin, Robert J Mayer
May 28, 2008·Journal of Cancer Research and Clinical Oncology·Kyriaki MystakidouLambros Vlahos
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Jun 27, 2008·Nucleic Acids Research·Jing ChenJian-Bing Fan
Aug 5, 2008·Cancer Research·Troels SchepelerClaus L Andersen
Aug 7, 2008·Pharmacogenomics·Silvia FunkeJenny Chang-Claude
Sep 9, 2008·Gastroenterology·William M Grady, John M Carethers
May 14, 2009·Bioinformatics·G L PapadopoulosA G Hatzigeorgiou
Aug 29, 2009·BMC Medical Genomics·Julie M CunninghamStephen N Thibodeau

❮ Previous
Next ❯

Citations

Jun 19, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Niamh Lynam-LennonStephen G Maher
Mar 12, 2013·International Journal of Colorectal Disease·Hui LiuChuanxin Wang
Oct 1, 2013·Molecular Biology Reports·Katarzyna HamaraJanusz Szemraj
Jun 19, 2010·Journal of Cardiovascular Translational Research·Aaron L Sarver
Feb 1, 2012·Cell Research·Guogen MaoGuo-Min Li
Nov 18, 2010·Carcinogenesis·William K K WuJoseph J Y Sung
Jan 31, 2012·Carcinogenesis·Alexander BaraniskinStephan A Hahn
Jun 1, 2012·The Cancer Journal·Aaron J SchetterCurtis C Harris
Aug 17, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francesc BalaguerAjay Goel
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela N BartleyStanley R Hamilton
Mar 8, 2011·Breast Cancer Research : BCR·Bethany N HannafonCarol L Rosenberg
Jul 4, 2012·Annals of Surgical Oncology·Suhu LiuAdam I Riker
Dec 20, 2012·RNA·Keerthana KrishnanSean M Grimmond
Feb 22, 2012·PloS One·Ander MuniateguiAngel Rubio
Nov 19, 2013·PloS One·Shiori FurukawaTetsu Akiyama
Nov 22, 2013·PloS One·Annika FendlerGeorge M Yousef
Jun 13, 2014·PloS One·Alessandra DruscoCarlo M Croce
Jul 15, 2011·Clinical and Experimental Gastroenterology·Claire M PayneHarris Bernstein
Mar 16, 2011·Pathology Research International·Nicole C Panarelli, Rhonda K Yantiss
Mar 13, 2014·International Journal of Genomics·Alessandra TessitoreEdoardo Alesse
Nov 19, 2013·Carcinogenesis·Katsuhiko NoshoYasuhisa Shinomura
Jul 27, 2011·Sarcoma·Rishi R LullaMarcelo B Soares
May 9, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Carlos Marino Cabral Calvano FilhoEdmund Chada Baracat
Mar 6, 2012·Current Colorectal Cancer Reports·Michael Schnekenburger, Marc Diederich
Sep 24, 2013·Expert Opinion on Therapeutic Targets·Valeria AmodeoAntonio Russo

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE18392

Methods Mentioned

BETA
PCR

Software Mentioned

Cluster
BeadStudio package
C Clustering Library
Diana miRpath
Kegg
miRpath
Illumina
Custom Perl scripts
R library affy
TreeView

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.